Pari Pharma GmbH
USPTO PatentsView assignee record - 35 granted patents across 14 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Pari ranks #9,102 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 14 technology areas.
- #9,102
- of 49,997 US assignees by volume
- Top 29%
- by Innovation Score (43.1/100)
- 18.0
- avg claims per patent
- -41%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R9102 · Foreign Corporation #9,102 · 35 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 35 grants
- UPPER-Q #9,102/49,997
- PHOTO-FINISH Occlutech
- CPC-FOCUS A61M · 14 areas
- INNOV-PAR 43.1/100
- CLAIMS-RICH 18.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -41% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Occlutech GmbH (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Pari’s 43.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Pari
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Pari Pharma · this assignee
Pari Pharma · this assignee
43 score
- Security People · near
Security People · near
43 score
- The Joan and Irwin… · near
The Joan and Irwin… · near
43 score
- Varroc Lighting… · near
Varroc Lighting… · near
43 score
- Volta Charging · near
Volta Charging · near
43 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Pari's Innovation Score is 43.1/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Pari?
Each dot is one of Pari’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pari’s own 18.0 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Pari's grants concentrate
Pari Pharma GmbH is a focused PatentsView assignee: 14 CPC subclasses with 80% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (7 grants) versus a trough of 1 in 2018. By volume, Pari sits between Other LAB, LLC and Profound Medical Inc..
Pari's three-year grant acceleration
Pari Pharma GmbH shows 8 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Pari's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Other LAB
Other LAB, LLC
35 patents
- Occlutech
Occlutech GmbH
35 patents
- P&W Solutions
P&W Solutions Co., Ltd.
35 patents
- Panasonic Semicon…
Panasonic Semiconductor Solutions Co., Ltd.
35 patents
- Pluto
Pluto Inc.
35 patents
- Polymer Technolog…
Polymer Technology Systems, Inc.
35 patents
- Portland State Un…
Portland State University
35 patents
- Profound Medical
Profound Medical Inc.
35 patents
- Pari Pharma ◀
Pari Pharma GmbH
35 patents
What this shows Pari holds 35 patents at rank #9,101, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Pari
By rank, the assignees closest to #9,101 in granted patent volume.
- Other LAB, LLC #9,097 · 35 patents
- Occlutech GmbH #9,098 · 35 patents
- P&W Solutions Co., Ltd. #9,099 · 35 patents
- Panasonic Semiconductor Solutions Co., Ltd. #9,100 · 35 patents
- Pluto Inc. #9,102 · 35 patents
- Polymer Technology Systems, Inc. #9,103 · 35 patents
- Portland State University #9,104 · 35 patents
- Profound Medical Inc. #9,105 · 35 patents
Leaders in A61M (Devices FOR Introducing Media Into)
Other assignees with the most granted patents in Pari's primary technology class.
- Becton, Dickinson and Company 1,249 in class
- Sanofi-Aventis Deutschland GMBH 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.V. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien LP 726 in class
- Terumo Kabushiki Kaisha 724 in class
- ResMed Pty Ltd 682 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Pari, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Pari ranks #251 of 3,490 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (43 here).
Pari's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 20.0% |
| 2016 | 5 | 14.3% |
| 2017 | 6 | 17.1% |
| 2018 | 1 | 2.9% |
| 2019 | 3 | 8.6% |
| 2020 | 3 | 8.6% |
| 2021 | 2 | 5.7% |
| 2022 | 4 | 11.4% |
| 2023 | 3 | 8.6% |
| 2024 | 1 | 2.9% |
Which technologies does Pari Pharma GmbH patent most?
Top 14 of 14 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Pari Pharma GmbH's patent record in context - here's where to go next.
- Pari Pharma GmbH's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 80% of its portfolio - see every assignee active in that class. Explore A61M
- Ranked #9,102 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Pari Pharma GmbH against Other LAB, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.